Yair Einhorn
@yaireinhorn
#Science & #Innovation. Special interest in #BioTech, #GeneEditing, #EpiGeneticEditing, #GeneTherapy 🧬 #CRISPR & #Ophthalmology. #Markets & #Stocks 📈
ID:1238780417324580867
14-03-2020 10:54:12
8,4K Tweets
7,5K Followers
46 Following
Follow People
Here’s an old CNBC interview of Mammoth Biosciences’s CEO - Trevor Martin in which he discuss Mammoth’s partnership with Bayer AG (‘22) aimed to develop Gene therapies in the liver. I can only assume that Mammoth’s recent $REGN collaboration is relevant to all non-liver targets. $XBI